Khajuria Ankur, Krzak Ada M, Reddy Rohin K, Lai Kenneth, Wignakumar Thirushan, Rohrich Rod J
Department of Surgery and Cancer, Imperial College London, London, United Kingdom.
Kellogg College, University of Oxford, Oxford, United Kingdom.
Plast Reconstr Surg Glob Open. 2022 Nov 23;10(11):e4673. doi: 10.1097/GOX.0000000000004673. eCollection 2022 Nov.
Previous systematic reviews evaluating piezoelectric osteotomy are of critically low quality. We conducted a high-quality systematic review and meta-analysis to evaluate outcomes for piezoelectric versus conventional osteotomy.
The study protocol was published a priori (PROSPERO: CRD42021287877). MEDLINE, Embase, Web of Science, and CENTRAL were searched for studies comparing piezoelectric versus conventional osteotomes and reporting at least one outcome of interest (clinical or patient-reported outcomes, PROs). Methodological quality and risk of bias were assessed using GRADE and Cochrane's RoB-2/ROBINS-I tools, respectively. Random effects models were applied.
Of 347 articles, 10 studies (nine randomized controlled trials; one prospective cohort study) including 554 patients were included. Piezoelectric osteotomy was associated with significantly reduced edema [standardized mean difference (SMD), -0.67; 95% confidence interval (CI), -1.03 to -0.30; < 0.0004], ecchymosis (SMD, -0.93; 95% CI, -1.13 to -0.73; < 0.00001), and pain (SMD, -1.48; 95% CI, -2.07 to -0.88; < 0.00001) compared with standard osteotomy. Odds of mucosal injury were significantly lower following piezoelectric osteotomy (odds ratio, 0.06; 95% CI, 0.01 to 0.52; = 0.01). There was no difference in duration of osteotomy (SMD, 3.15; 95% CI, -1.82 to 8.12; = 0.22) or total procedure duration (SMD, 0.46; 95% CI, -0.43 to 1.36; = 0.31). One study reported PROs, favoring piezoelectric osteotomy.
This systematic review and meta-analysis provides support (albeit weak, due to low-quality evidence) for piezoelectric over conventional osteotomy, for reducing morbidity in the early postoperative period. High-quality level I data reporting PROs will optimize shared decision-making/informed consent.
先前评估压电截骨术的系统评价质量极低。我们进行了一项高质量的系统评价和荟萃分析,以评估压电截骨术与传统截骨术的疗效。
研究方案已预先发表(PROSPERO:CRD42021287877)。检索了MEDLINE、Embase、Web of Science和CENTRAL数据库,以查找比较压电截骨术与传统截骨凿并报告至少一项感兴趣结局(临床或患者报告结局,PROs)的研究。分别使用GRADE和Cochrane的RoB-2/ROBINS-I工具评估方法学质量和偏倚风险。应用随机效应模型。
在347篇文章中,纳入了10项研究(9项随机对照试验;1项前瞻性队列研究),共554例患者。与标准截骨术相比,压电截骨术可显著减轻水肿[标准化均数差(SMD),-0.67;95%置信区间(CI),-1.03至-0.30;P<0.0004]、瘀斑(SMD,-0.93;95%CI,-1.13至-0.73;P<0.00001)和疼痛(SMD,-1.48;95%CI,-2.07至-0.88;P<0.00001)。压电截骨术后黏膜损伤的几率显著降低(比值比,0.06;95%CI,0.01至0.52;P=0.01)。截骨持续时间(SMD,3.15;95%CI,-1.82至8.12;P=0.22)或总手术持续时间(SMD,0.46;95%CI,-0.43至1.36;P=0.31)无差异。一项研究报告了PROs,支持压电截骨术。
这项系统评价和荟萃分析为压电截骨术优于传统截骨术以降低术后早期发病率提供了支持(尽管由于证据质量低而较弱)。报告PROs的高质量I级数据将优化共同决策/知情同意。